🌍·Mar 7, 2023Industry
perspectivehighlights
Publisher
P
Perspective Therapeutics
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Perspective Therapeutics
- Region
- 最新
- Scope
- Industry
- Published
- March 7, 2023
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on perspective.com
Leave the platform to read the original full article on the publisher site.
Source: Perspective Therapeutics
Scope: Industry
Related coverage
More related coverage
AbelZeta Pharma/19h ago
AbelZeta Receives EMA PRIME Designation for C-CAR168 in Lupus Nephritis and Systemic Lupus Erythematosus
CPI (Healthcare Innovation)/18h ago
CPI partners with XeleratedFifty to accelerate UK deep tech innovation globally
<![CDATA[Intermountain Health Newsroom]]>/19h ago
How a Primary Care Partnership at Intermountain Health Changed Billings Woman’s Outlook and Health
Certara/20h ago